Literature DB >> 21760508

Comprehensive care of the patient with idiopathic pulmonary fibrosis.

Joyce S Lee1, Sally McLaughlin, Harold R Collard.   

Abstract

PURPOSE OF REVIEW: Recently, an expert committee endorsed by the American Thoracic Society, European Respiratory Society, Japanese Respiratory Society, and the Latin American Thoracic Society published an evidence-based guideline on the management of idiopathic pulmonary fibrosis (IPF). In the current document, we summarize and supplement this recent expert document and propose a comprehensive approach to the care and management of patients with IPF. RECENT
FINDINGS: We propose three pillars of care for the patient with IPF titled 'disease-centered management', 'symptom-centered management', and 'education and self-management'. Disease-centered management involves both pharmacological and nonpharmacological approaches. Palliative care should be an integral and routine component of the care of patients with IPF. Education and self-management strengthens the provider-patient partnership by enabling patients to set realistic goals, remain in control of his or her care, and prepare for the future.
SUMMARY: The comprehensive care of the patient with IPF involves balancing the three pillars of disease-centered management, symptom-centered management, and patient education and self-management upon a solid foundation of provider-patient partnership. Constant reassessment of the individual patient's goals of care, based on their values and preferences, is essential to the constant recalibration of these various interventions.

Entities:  

Mesh:

Year:  2011        PMID: 21760508     DOI: 10.1097/MCP.0b013e328349721b

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  19 in total

1.  Palliative care and location of death in decedents with idiopathic pulmonary fibrosis.

Authors:  Kathleen O Lindell; Zhan Liang; Leslie A Hoffman; Margaret Q Rosenzweig; Melissa I Saul; Joseph M Pilewski; Kevin F Gibson; Naftali Kaminski
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

2.  The palliative care needs of patients with idiopathic pulmonary fibrosis: A qualitative study of patients and family caregivers.

Authors:  Kathleen Oare Lindell; Dio Kavalieratos; Kevin F Gibson; Laura Tycon; Margaret Rosenzweig
Journal:  Heart Lung       Date:  2016-11-18       Impact factor: 2.210

Review 3.  Optimizing quality of life in patients with idiopathic pulmonary fibrosis.

Authors:  Mirjam J G van Manen; J J Miranda Geelhoed; Nelleke C Tak; Marlies S Wijsenbeek
Journal:  Ther Adv Respir Dis       Date:  2017-01-01       Impact factor: 4.031

4.  Idiopathic Pulmonary Fibrosis and the Elderly: Diagnosis and Management Considerations.

Authors:  Helen E Jo; Sharan Randhawa; Tamera J Corte; Yuben Moodley
Journal:  Drugs Aging       Date:  2016-05       Impact factor: 3.923

Review 5.  Identification of Key Cost Generating Events for Idiopathic Pulmonary Fibrosis: A Systematic Review.

Authors:  Shalvaree Vaidya; Clare L Hibbert; Elizabeth Kinter; Stefan Boes
Journal:  Lung       Date:  2016-11-19       Impact factor: 2.584

6.  [Treatment of pulmonary fibrosis. New substances and new interventions].

Authors:  U Costabel; F Bonella
Journal:  Internist (Berl)       Date:  2011-12       Impact factor: 0.743

7.  N-acetylcysteine alleviates angiotensin II-mediated renal fibrosis in mouse obstructed kidneys.

Authors:  Yang Shen; Nai-Jun Miao; Jin-Lan Xu; Xin-Xin Gan; Dan Xu; Li Zhou; Hong Xue; Wei Zhang; Li-Min Lu
Journal:  Acta Pharmacol Sin       Date:  2016-04-04       Impact factor: 6.150

8.  Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges.

Authors:  Paolo Spagnolo; Roberto Tonelli; Elisabetta Cocconcelli; Alessandro Stefani; Luca Richeldi
Journal:  Multidiscip Respir Med       Date:  2012-11-12

9.  Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo.

Authors:  L Zhang; Y X Ji; W L Jiang; C J Lv
Journal:  Braz J Med Biol Res       Date:  2015-05-08       Impact factor: 2.590

10.  Idiopathic pulmonary fibrosis: the need for early diagnosis.

Authors:  Gaetano Cicchitto; Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2013-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.